Sandboxing, demonstrated value, and a hard line at clinical judgment: a physician-researcher’s three-question test before AI touches a trial.
- Inside The Rush To Accelerated Approval: A Consultant's View
- Why Virtua Health's AI Committee Gives IT The Review, Not The Vote
- Building Effective, Retrospective Decision-Grade Disease Registries
- To Pick The Right Medical LLM, First Assess Your Readiness
- Clinical Trial Tech Fails On Systems, Not Software
- Inside A Sponsor-Site Relationship That Actually Worked
- Real-World Data Won't Replace Trials. Here's Its Real Job
- Inside Virtua Health's Pipeline For Anonymizing Trial Imaging Data
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
The One Moment You Have Leverage In A Clinical Trial, And Why It Disappears Fast
Discover how to maintain strategic leverage during vendor selection. Learn to identify flexible, long-term partners who keep clinical trials on track before contracts are signed.
-
Collecting Trial Data From Patients In Remote Areas
Learn how mobile technology can promote trial inclusivity and diversity, and its potential to revolutionize clinical studies, making them more accessible and representative of the population.
-
Digital Advancements In Clinical Development - What's Next?
Review this year's predictions for improving digital biomarkers and data analytics, bettering endpoint sensitivity and specificity, and reducing timelines and costs of clinical development.
-
Beginner's Guide To 21 CFR Part 11 Compliance
Computer systems used for clinical trials fall under Food and Drug Administration (FDA) 21 CFR Part 11. While Part 11 is widely known, this blog explains how it fits in with your research software.
-
Bringing Clinical Research To The Patient Using Patient-Centric Tech
By fostering daily interactions between patients and technology, these smart hubs offer a sustainable approach to ensuring the success and integrity of clinical trials in an evolving landscape of drug development.
-
Sustainable Clinical Trials Through eClinical Innovation
Clinical trials are essential to advancing medicine, yet they carry significant environmental costs. Inefficiencies not only drive emissions but also risk drug shortages and trial delays, and clinical technology solutions offer a pathway to more sustainable research.
-
Cagey Sponsors, Defensive Vendors: Observations On How Transparency Breaks Down
Discover how hidden operational uncertainties trigger defensive pricing and scope disputes—and how early transparency builds stable, high-performing research partnerships.
-
Running Compliant Studies Without Enterprise EDC Overhead
Low-complexity medical device and IVD studies often fall between enterprise EDC systems and spreadsheets. This webinar shows how a compliant, audit-ready alternative works in practice.
-
How Medidata Link Is Supporting Moderna's Clinical Trial Real-World Data Linkage Initiatives
Discover how Medidata Link empowers Moderna's clinical trial RWD linkage initiatives, enhancing insights into treatment outcomes while minimizing administrative burdens.
-
Vendor Selection Bias: Why Structured Decisions Often Fail
Learn how subtle influences derail decisions and discover proven safeguards that promote transparency, accountability, and shared ownership for better trial outcomes.
- A Framework For Deploying AI In Clinical Trials Without The Hype
- Why Younger Clinical Researchers Are More Wary Of AI Than Their Elders
- Inside The Rush To Accelerated Approval: A Consultant's View
- Why Virtua Health's AI Committee Gives IT The Review, Not The Vote
- Clinical Trial Tech Fails On Systems, Not Software
RECENT NEWSLETTERS
- 10.15.26 -- AI, Site Burden, And Vendor Risks Are Testing Trials
- 10.08.26 -- AI, RTSM, And Trial Systems Are Still Breaking Down
- 10.03.26 -- Best Of September: AI, Wearables, And Trial Workflow Gaps
- 10.01.26 -- AI, Data Integrity, And Wireless Gaps Are Reshaping Trials
- 09.24.26 -- AI, Wearables, And CRA Workflows Are Exposing Trial Gaps